Mark Timney Speaks at the BIO CEO & Investor Conference

Mark Timney, CEO of Purdue Pharma L.P., participated in a BIO Buzz Center interview with Luke Timmerman about diversification opportunities during the 2016 BIO CEO & Investor Conference on February 8 in New York. (Watch the video interview embedded below.)

During the conference, Mark was a featured panelist for, “M&A in Overdrive: Deal-Making and Merger Integration Success Factors.” Stephen B. Thau, partner at Morrison & Foerster, served as the moderator. The other panelists included Henry Gosebruch, EVP and Chief Strategy Officer, AbbVie; Carol Gallagher, Partner, New Enterprise Associates; and James Sapirstein, CEO, ContraVir Pharmaceuticals. The conference, one of the largest investor conferences focused on biotech companies, provides a forum for institutional investors, industry analysts and senior biotechnology executives to meet.